1
|
Bigham NP, Novorolsky RJ, Davis KR, Zou H, MacMillan SN, Stevenson MJ, Robertson GS, Wilson JJ. Supramolecular delivery of dinuclear ruthenium and osmium MCU inhibitors. Inorg Chem Front 2024; 11:5064-5079. [PMID: 39113903 PMCID: PMC11301636 DOI: 10.1039/d4qi01102c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2024] [Accepted: 07/03/2024] [Indexed: 08/10/2024]
Abstract
The transmembrane protein known as the mitochondrial calcium uniporter (MCU) mediates the influx of calcium ions (Ca2+) into the mitochondrial matrix. An overload of mitochondrial Ca2+ ( m Ca2+) is directly linked to damaging effects in pathological conditions. Therefore, inhibitors of the MCU are important chemical biology tools and therapeutic agents. Here, two new analogues of previously reported Ru- and Os-based MCU inhibitors Ru265 and Os245, of the general formula [(C10H15CO2)M(NH3)4(μ-N)M(NH3)4(O2CC10H15)](CF3SO3)3, where M = Ru (1) or Os (2), are reported. These analogues bear adamantane functional groups, which were installed to act as guests for the host molecule cucurbit-[7]-uril (CB[7]). These complexes were characterized and analyzed for their efficiency as guests for CB[7]. As shown through a variety of spectroscopic techniques, each adamantane ligand is encapsulated into one CB[7], affording a supramolecular complex of 1 : 2 stoichiometry. The biological effects of these compounds in the presence and absence of two equiv. CB[7] were assessed. Both complexes 1 and 2 exhibit enhanced cellular uptake compared to the parent compounds Ru265 and Os245, and their uptake is increased further in the presence of CB[7]. Compared to Ru265 and Os245, 1 and 2 are less potent as m Ca2+ uptake inhibitors in permeabilized cell models. However, in intact cell systems, 1 and 2 inhibit the MCU at concentrations as low as 1 μM, marking an advantage over Ru265 and Os245 which require an order of magnitude higher doses for similar biological effects. The presence of CB[7] did not affect the inhibitory properties of 1 and 2. Experiments in primary cortical neurons showed that 1 and 2 can elicit protective effects against oxygen-glucose deprivation at lower doses than those required for Ru265 or Os245. At low concentrations, the protective effects of 1 were modulated by CB[7], suggesting that supramolecular complex formation can play a role in these biological conditions. The in vivo biocompatibility of 1 was investigated in mice. The intraperitoneal administration of these compounds and their CB[7] complexes led to time-dependent induction of seizures with no protective effects elicited by CB[7]. This work demonstrates the potential for supramolecular interactions in the development of MCU inhibitors.
Collapse
Affiliation(s)
- Nicholas P Bigham
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
| | - Robyn J Novorolsky
- Department of Pharmacology, Faculty of Medicine, Dalhousie University 6th Floor Sir Charles Tupper Medical Building Halifax B3H 4R2 Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 4R2 Canada
| | - Keana R Davis
- Department of Chemistry, University of San Francisco San Francisco CA 94117 USA
| | - Haipei Zou
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
- Department of Chemistry & Biochemistry, University of California Santa Barbara Santa Barbara CA 93106 USA
| | - Samantha N MacMillan
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
| | - Michael J Stevenson
- Department of Chemistry, University of San Francisco San Francisco CA 94117 USA
| | - George S Robertson
- Department of Pharmacology, Faculty of Medicine, Dalhousie University 6th Floor Sir Charles Tupper Medical Building Halifax B3H 4R2 Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 4R2 Canada
- Department of Psychiatry, Faculty of Medicine, Dalhousie University Halifax NS B3H 2E2 Canada
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
- Department of Chemistry & Biochemistry, University of California Santa Barbara Santa Barbara CA 93106 USA
| |
Collapse
|
2
|
Amjid U, Aziz U, Habib U, Jabeen I. Biological regulatory network analysis for targeting the mitochondrial calcium uniporter (MCU) mediated calcium (Ca 2+) transport in neurodegenerative disorders. Cell Biochem Funct 2024; 42:e4082. [PMID: 38944766 DOI: 10.1002/cbf.4082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2024] [Revised: 05/30/2024] [Accepted: 06/18/2024] [Indexed: 07/01/2024]
Abstract
Calcium (Ca2+) has been observed as the most important ion involved in a series of cellular processes and its homeostasis is critical for normal cellular functions. Mitochondrial calcium uniporter (MCU) complex has been recognized as the most important calcium-specific channel located in the inner mitochondrial membrane and is one of the major players in maintaining the Ca2+ homeostasis by transporting Ca2+ across the mitochondrial membrane. Furthermore, dysregulation of the mitochondrial Ca2+ homeostasis has been orchestrated to neurodegenerative response. This necessitates quantitative evaluation of the MCU-dependent mROS production and subsequent cellular responses for more specific therapeutic interventions against neurodegenerative disorders. Towards this goal, here we present a biological regulatory network of MCU to dynamically simulate the MCU-mediated ROS production and its response in neurodegeneration. Previously, ruthenium complex RuRed and its derivatives have been reported to show low nM to high µM potency against MCU to maintain cytosolic Ca2+ (cCa2+) homeostasis by modulating mitochondrial Ca2+ (mCa2+) uptake. Therefore, structural modeling and dynamic simulation of MCU pore-forming subunit is performed to probe the interaction profiling of previously reported Ru265 and its derivatives compounds with MCU. The current study highlighted MCU as a potential drug target in neurodegenerative disorders. Furthermore, ASP261 and GLU264 amino acid residues in DIME motif of MCU pore-forming subunits are identified as crucial for modulating the activity of MCU in neurodegenerative disorders.
Collapse
Affiliation(s)
- Umar Amjid
- School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences & Technology (NUST), Islamabad, Pakistan
- Department of Paediatrics and Child Health, Medical College, Aga Khan University Hospital, Karachi, Pakistan
| | - Ubair Aziz
- School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences & Technology (NUST), Islamabad, Pakistan
| | - Uzma Habib
- School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences & Technology (NUST), Islamabad, Pakistan
| | - Ishrat Jabeen
- School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences & Technology (NUST), Islamabad, Pakistan
| |
Collapse
|
3
|
Sasaki H, Nakagawa I, Furuta T, Yokoyama S, Morisaki Y, Saito Y, Nakase H. Mitochondrial Calcium Uniporter (MCU) is Involved in an Ischemic Postconditioning Effect Against Ischemic Reperfusion Brain Injury in Mice. Cell Mol Neurobiol 2024; 44:32. [PMID: 38568450 PMCID: PMC10991049 DOI: 10.1007/s10571-024-01464-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2023] [Accepted: 02/21/2024] [Indexed: 04/05/2024]
Abstract
The phenomenon of ischemic postconditioning (PostC) is known to be neuroprotective against ischemic reperfusion (I/R) injury. One of the key processes in PostC is the opening of the mitochondrial ATP-dependent potassium (mito-KATP) channel and depolarization of the mitochondrial membrane, triggering the release of calcium ions from mitochondria through low-conductance opening of the mitochondrial permeability transition pore. Mitochondrial calcium uniporter (MCU) is known as a highly sensitive transporter for the uptake of Ca2+ present on the inner mitochondrial membrane. The MCU has attracted attention as a new target for treatment in diseases, such as neurodegenerative diseases, cancer, and ischemic stroke. We considered that the MCU may be involved in PostC and trigger its mechanisms. This research used the whole-cell patch-clamp technique on hippocampal CA1 pyramidal cells from C57BL mice and measured changes in spontaneous excitatory post-synaptic currents (sEPSCs), intracellular Ca2+ concentration, mitochondrial membrane potential, and N-methyl-D-aspartate receptor (NMDAR) currents under inhibition of MCU by ruthenium red 265 (Ru265) in PostC. Inhibition of MCU increased the occurrence of sEPSCs (p = 0.014), NMDAR currents (p < 0.001), intracellular Ca2+ concentration (p < 0.001), and dead cells (p < 0.001) significantly after reperfusion, reflecting removal of the neuroprotective effects in PostC. Moreover, mitochondrial depolarization in PostC with Ru265 was weakened, compared to PostC (p = 0.004). These results suggest that MCU affects mitochondrial depolarization in PostC to suppress NMDAR over-activation and prevent elevation of intracellular Ca2+ concentrations against I/R injury.
Collapse
Affiliation(s)
- Hiromitsu Sasaki
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| | - Ichiro Nakagawa
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan.
| | - Takanori Furuta
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| | - Shohei Yokoyama
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| | - Yudai Morisaki
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| | - Yasuhiko Saito
- Department of Neurophysiology, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| | - Hiroyuki Nakase
- Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan
| |
Collapse
|
4
|
Huang Z, Wilson JJ. Structure-Activity Relationships of Metal-Based Inhibitors of the Mitochondrial Calcium Uniporter. ChemMedChem 2023; 18:e202300106. [PMID: 37015871 DOI: 10.1002/cmdc.202300106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 04/01/2023] [Accepted: 04/04/2023] [Indexed: 04/06/2023]
Abstract
The mitochondrial calcium uniporter (MCU) is a transmembrane protein that is responsible for mediating mitochondrial calcium (mCa2+ ) uptake. Given this critical function, the MCU has been implicated as an important target for addressing various human diseases. As such, there has a been growing interest in developing small molecules that can inhibit this protein. To date, metal coordination complexes, particularly multinuclear ruthenium complexes, are the most widely investigated MCU inhibitors due to both their potent inhibitory activities as well as their longstanding use for this application. Recent efforts have expanded the metal-based toolkit for MCU inhibition. This concept paper summarizes the development of new metal-based inhibitors of the MCU and their structure-activity relationships in the context of improving their potential for therapeutic use in managing human diseases related to mCa2+ dysregulation.
Collapse
Affiliation(s)
- Zhouyang Huang
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
| |
Collapse
|
5
|
De Mario A, D'Angelo D, Zanotti G, Raffaello A, Mammucari C. The mitochondrial calcium uniporter complex–A play in five acts. Cell Calcium 2023; 112:102720. [PMID: 37001308 DOI: 10.1016/j.ceca.2023.102720] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 03/22/2023] [Accepted: 03/23/2023] [Indexed: 03/30/2023]
Abstract
Mitochondrial Ca2+ (mitCa2+) uptake controls both intraorganellar and cytosolic functions. Within the organelle, [Ca2+] increases regulate the activity of tricarboxylic acid (TCA) cycle enzymes, thus sustaining oxidative metabolism and ATP production. Reactive oxygen species (ROS) are also generated as side products of oxygen consumption. At the same time, mitochondria act as buffers of cytosolic Ca2+ (cytCa2+) increases, thus regulating Ca2+-dependent cellular processes. In pathological conditions, mitCa2+ overload triggers the opening of the mitochondrial permeability transition pore (mPTP) and the release of apoptotic cofactors. MitCa2+ uptake occurs in response of local [Ca2+] increases in sites of proximity between the endoplasmic reticulum (ER) and the mitochondria and is mediated by the mitochondrial Ca2+ uniporter (MCU), a highly selective channel of the inner mitochondrial membrane (IMM). Both channel and regulatory subunits form the MCU complex (MCUC). Cryogenic electron microscopy (Cryo-EM) and crystal structures revealed the correct assembly of MCUC and the function of critical residues for the regulation of Ca2+ conductance.
Collapse
|
6
|
Bigham NP, Wilson JJ. Investigation of Cobalt(III) Cage Complexes as Inhibitors of the Mitochondrial Calcium Uniporter. Eur J Inorg Chem 2023; 26:e202200735. [PMID: 37636126 PMCID: PMC10449033 DOI: 10.1002/ejic.202200735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Indexed: 01/18/2023]
Abstract
The mitochondrial calcium uniporter (MCU) mediates uptake of calcium ions (Ca2+) into the mitochondria, a process that is vital for maintaining normal cellular function. Inhibitors of the MCU, the most promising of which are dinuclear ruthenium coordination compounds, have found use as both therapeutic agents and tools for studying the importance of this ion channel. In this study, six Co3+ cage compounds with sarcophagine-like ligands were assessed for their abilities to inhibit MCU-mediated mitochondrial Ca2+ uptake. These complexes were synthesized and characterized according to literature procedures and then investigated in cellular systems for their MCU-inhibitory activities. Among these six compounds, [Co(sen)]3+ (3, sen = 5-(4-amino-2-azabutyl)-5-methyl-3,7-diaza-1,9-nonanediamine) was identified to be a potent MCU inhibitor, with IC50 values of inhibition of 160 and 180 nM in permeabilized HeLa and HEK293T cells, respectively. Furthermore, the cellular uptake of compound 3 was determined, revealing moderate accumulation in cells. Most notably, 3 was demonstrated to operate in intact cells as an MCU inhibitor. Collectively, this work presents the viability of using cobalt coordination complexes as MCU inhibitors, providing a new direction for researchers to investigate in future studies.
Collapse
Affiliation(s)
- Nicholas P Bigham
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA
| |
Collapse
|
7
|
Huang Z, MacMillan SN, Wilson JJ. A Fluorogenic Inhibitor of the Mitochondrial Calcium Uniporter. Angew Chem Int Ed Engl 2023; 62:e202214920. [PMID: 36515400 PMCID: PMC9892296 DOI: 10.1002/anie.202214920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 12/12/2022] [Accepted: 12/14/2022] [Indexed: 12/15/2022]
Abstract
Inhibitors of the mitochondrial calcium uniporter (MCU) are valuable tools for studying the role of mitochondrial Ca2+ in various pathophysiological conditions. In this study, a new fluorogenic MCU inhibitor, RuOCou, is presented. This compound is an analogue of the known MCU inhibitor Ru265 that contains fluorescent axial coumarin carboxylate ligands. Upon aquation of RuOCou and release of the axial coumarin ligands, a simultaneous increase in its MCU-inhibitory activity and fluorescence intensity is observed. The fluorescence response of this compound enabled its aquation to be monitored in both HeLa cell lysates and live HeLa cells. This fluorogenic prodrug represents a potential theranostic MCU inhibitor that can be leveraged for the treatment of human diseases related to MCU activity.
Collapse
Affiliation(s)
- Zhouyang Huang
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
| | - Samantha N MacMillan
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
| |
Collapse
|
8
|
Woods JJ, Novorolsky RJ, Bigham NP, Robertson GS, Wilson JJ. Dinuclear nitrido-bridged osmium complexes inhibit the mitochondrial calcium uniporter and protect cortical neurons against lethal oxygen-glucose deprivation. RSC Chem Biol 2023; 4:84-93. [PMID: 36685255 PMCID: PMC9811523 DOI: 10.1039/d2cb00189f] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Accepted: 11/05/2022] [Indexed: 11/16/2022] Open
Abstract
Dysregulation of mitochondrial calcium uptake mediated by the mitochondrial calcium uniporter (MCU) is implicated in several pathophysiological conditions. Dinuclear ruthenium complexes are effective inhibitors of the MCU and have been leveraged as both tools to study mitochondrial calcium dynamics and potential therapeutic agents. In this study, we report the synthesis and characterization of Os245 ([Os2(μ-N)(NH3)8Cl2]3+) which is the osmium-containing analogue of our previously reported ruthenium-based inhibitor Ru265. This complex and its aqua-capped analogue Os245' ([Os2(μ-N)(NH3)8(OH2)2]5+) are both effective inhibitors of the MCU in permeabilized and intact cells. In comparison to the ruthenium-based inhibitor Ru265 (k obs = 4.92 × 10-3 s-1), the axial ligand exchange kinetics of Os245 are two orders of magnitude slower (k obs = 1.63 × 10-5 s-1) at 37 °C. The MCU-inhibitory properties of Os245 and Os245' are different (Os245 IC50 for MCU inhibition = 103 nM; Os245' IC50 for MCU inhibition = 2.3 nM), indicating that the axial ligands play an important role in their interactions with this channel. We further show that inhibition of the MCU by these complexes protects primary cortical neurons against lethal oxygen-glucose deprivation. When administered in vivo to mice (10 mg kg-1), Os245 and Os245' induce seizure-like behaviors in a manner similar to the ruthenium-based inhibitors. However, the onset of these seizures is delayed, a possible consequence of the slower ligand substitution kinetics for these osmium complexes. These findings support previous studies that demonstrate inhibition of the MCU is a promising therapeutic strategy for the treatment of ischemic stroke, but also highlight the need for improved drug delivery strategies to mitigate the pro-convulsant effects of this class of complexes before they can be implemented as therapeutic agents. Furthermore, the slower ligand substitution kinetics of the osmium analogues may afford new strategies for the development and modification of this class of MCU inhibitors.
Collapse
Affiliation(s)
- Joshua J Woods
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
- Robert F. Smith School for Chemical and Biomolecular Engineering, Cornell University Ithaca NY 14853 USA
| | - Robyn J Novorolsky
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 0A8 Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 0A8 Canada
| | - Nicholas P Bigham
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
| | - George S Robertson
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 0A8 Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H 0A8 Canada
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Life Sciences Research Institute Halifax NS B3H0A8 Canada
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University Ithaca NY 14853 USA
| |
Collapse
|
9
|
Huang Z, Spivey JA, MacMillan SN, Wilson JJ. A ferrocene-containing analogue of the MCU inhibitor Ru265 with increased cell permeability. Inorg Chem Front 2023. [DOI: 10.1039/d2qi02183h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
An analogue of the mitochondrial calcium uniporter (MCU) inhibitor Ru265 containing axial ferrocenecarboxylate ligands is reported. This new complex exhibits enhanced cellular uptake compared to the parent compound Ru265.
Collapse
Affiliation(s)
- Zhouyang Huang
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA
| | - Jesse A. Spivey
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA
| | - Samantha N. MacMillan
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA
| | - Justin J. Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA
| |
Collapse
|
10
|
Bigham NP, Huang Z, Spivey J, Woods JJ, MacMillan SN, Wilson JJ. Carboxylate-Capped Analogues of Ru265 Are MCU Inhibitor Prodrugs. Inorg Chem 2022; 61:17299-17312. [PMID: 36260092 DOI: 10.1021/acs.inorgchem.2c02930] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
The mitochondrial calcium uniporter (MCU) is a transmembrane protein that resides on the inner membrane of the mitochondria and mediates calcium uptake into this organelle. Given the critical role of mitochondrial calcium trafficking in cellular function, inhibitors of this channel have arisen as tools for studying the biological relevance of this process and as potential therapeutic agents. In this study, four new analogues of the previously reported Ru-based MCU inhibitor [ClRu(NH3)4(μ-N)Ru(NH3)4Cl]Cl3 (Ru265) are reported. These compounds, which bear axial carboxylate ligands, are of the general formula [(RCO2)Ru(NH3)4(μ-N)Ru(NH3)4(O2CR)]X3, where X = NO3- or CF3SO3- and R = H (1), CH3 (2), CH2CH3 (3), and (CH2)2CH3 (4). These complexes were fully characterized by IR spectroscopy, NMR spectroscopy, and elemental analysis. X-ray crystal structures of 1 and 3 were obtained, revealing the expected presence of both the linear Ru(μ-N)Ru core and axial formate and propionate ligands. The axial carboxylate ligands of complexes 1-4 are displaced by water in buffered aqueous solution to give the aquated compound Ru265'. The kinetics of these processes were measured by 1H NMR spectroscopy, revealing half-lives that span 5.9-9.9 h at 37 °C. Complex 1 with axial formate ligands underwent aquation approximately twice as fast as the other compounds. In vitro cytotoxicity and mitochondrial membrane potential measurements carried out in HeLa and HEK293T cells demonstrated that none of these four complexes negatively affects cell viability or mitochondrial function. The abilities of 1-4 to inhibit mitochondrial calcium uptake in permeabilized HEK293T cells were assessed and compared to that of Ru265. Fresh solutions of 1-4 are approximately 2-fold less potent than Ru265 with IC50 values in the range of 14.7-19.1 nM. Preincubating 1-4 in aqueous buffers for longer time periods to allow for the aquation reactions to proceed increases their potency of mitochondrial uptake inhibition to match that of Ru265. This result indicates that 1-4 are aquation-activated prodrugs of Ru265'. Finally, 1-4 were shown to inhibit mitochondrial calcium uptake in intact, nonpermeabilized cells, revealing their value as tools and potential therapeutic agents for mitochondrial calcium-related disorders.
Collapse
Affiliation(s)
- Nicholas P Bigham
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Zhouyang Huang
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Jesse Spivey
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Joshua J Woods
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
- Robert F. Smith School of Engineering, Cornell University, Ithaca, New York 14853, United States
| | - Samantha N MacMillan
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| |
Collapse
|
11
|
Bolaños P, Calderón JC. Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research. Front Physiol 2022; 13:989796. [PMID: 36117698 PMCID: PMC9478590 DOI: 10.3389/fphys.2022.989796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 08/08/2022] [Indexed: 11/13/2022] Open
Abstract
The excitation–contraction coupling (ECC) in skeletal muscle refers to the Ca2+-mediated link between the membrane excitation and the mechanical contraction. The initiation and propagation of an action potential through the membranous system of the sarcolemma and the tubular network lead to the activation of the Ca2+-release units (CRU): tightly coupled dihydropyridine and ryanodine (RyR) receptors. The RyR gating allows a rapid, massive, and highly regulated release of Ca2+ from the sarcoplasmic reticulum (SR). The release from triadic places generates a sarcomeric gradient of Ca2+ concentrations ([Ca2+]) depending on the distance of a subcellular region from the CRU. Upon release, the diffusing Ca2+ has multiple fates: binds to troponin C thus activating the contractile machinery, binds to classical sarcoplasmic Ca2+ buffers such as parvalbumin, adenosine triphosphate and, experimentally, fluorescent dyes, enters the mitochondria and the SR, or is recycled through the Na+/Ca2+ exchanger and store-operated Ca2+ entry (SOCE) mechanisms. To commemorate the 7th decade after being coined, we comprehensively and critically reviewed “old”, historical landmarks and well-established concepts, and blended them with recent advances to have a complete, quantitative-focused landscape of the ECC. We discuss the: 1) elucidation of the CRU structures at near-atomic resolution and its implications for functional coupling; 2) reliable quantification of peak sarcoplasmic [Ca2+] using fast, low affinity Ca2+ dyes and the relative contributions of the Ca2+-binding mechanisms to the whole concert of Ca2+ fluxes inside the fibre; 3) articulation of this novel quantitative information with the unveiled structural details of the molecular machinery involved in mitochondrial Ca2+ handing to understand how and how much Ca2+ enters the mitochondria; 4) presence of the SOCE machinery and its different modes of activation, which awaits understanding of its magnitude and relevance in situ; 5) pharmacology of the ECC, and 6) emerging topics such as the use and potential applications of super-resolution and induced pluripotent stem cells (iPSC) in ECC. Blending the old with the new works better!
Collapse
Affiliation(s)
- Pura Bolaños
- Laboratory of Cellular Physiology, Centre of Biophysics and Biochemistry, Venezuelan Institute for Scientific Research (IVIC), Caracas, Venezuela
| | - Juan C. Calderón
- Physiology and Biochemistry Research Group-PHYSIS, Faculty of Medicine, University of Antioquia, Medellín, Colombia
- *Correspondence: Juan C. Calderón,
| |
Collapse
|
12
|
Yanda MK, Tomar V, Cole R, Guggino WB, Cebotaru L. The Mitochondrial Ca 2+ import complex is altered in ADPKD. Cell Calcium 2022; 101:102501. [PMID: 34823104 PMCID: PMC8840832 DOI: 10.1016/j.ceca.2021.102501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Revised: 11/05/2021] [Accepted: 11/06/2021] [Indexed: 01/03/2023]
Abstract
Mutations in either of the polycystic kidney disease genes, PKD1 or PKD2, engender the growth of cysts, altering renal function. Cystic growth is supported by major changes in cellular metabolism, some of which involve the mitochondrion, a major storage site for Ca2+ and a key organelle in cellular Ca2+ signaling. The goal here was to understand the role of components of the mitochondrial Ca2+ uptake complex in PC1-mutant cells in autosomal dominant polycystic kidney disease (ADPKD). We found that the mitochondrial Ca2+ uniporter (MCU) and voltage-dependent anion channels 1& 3 (VDAC) were down-regulated in different mouse and cell models of ADPKD along with the Ca2+-dependent enzyme, pyruvate dehydrogenase phosphatase (PDHX). The release of Ca2+ from the endoplasmic reticulum, and Ca2+ uptake by the mitochondria were upregulated in PC1(polycystin)-null cells. We also observed an enhanced staining with MitoTracker Red CMXRos in PC1-null cultured cells than in PC1-containing cells and a substantially higher increase in response to ER Ca2+ release. Increased colocalization of the Ca2+ sensitive dye, rhodamine2, with MitoTracker Green suggested an increase Ca2+ entry into the mitochondria in PC1 null cells subsequent to Ca2+ release from the ER or from Ca2+ entry from the extracellular solution. These data clearly demonstrate abnormal release of Ca2+ by the ER and corresponding alterations in Ca2+ uptake by the mitochondria in PC1-null cells. Importantly, inhibiting mitochondrial Ca2+ uptake with the specific inhibitor Ru360 inhibited cyst growth and altered both apoptosis and cell proliferation. We further show that the decrease in mitochondrial proteins and abnormally high Ca2+ signaling can be reversed by application of the cystic fibrosis (CFTR) corrector, VX-809. We conclude that enhanced Ca2+ signaling and alterations in proteins association with the mitochondrial Ca2+ uptake complex are associated with malfunction of PC1. Finally, our results identify novel therapeutic targets for treating ADPKD.
Collapse
Affiliation(s)
- Murali K Yanda
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Vartika Tomar
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Robert Cole
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - William B Guggino
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Liudmila Cebotaru
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
| |
Collapse
|
13
|
Woods JJ, Spivey JA, Wilson JJ. A [1H,15N] Heteronuclear Single Quantum Coherence NMR Study of the Solution Reactivity of the Ruthenium‐Based Mitochondrial Calcium Uniporter Inhibitor Ru265. Eur J Inorg Chem 2021. [DOI: 10.1002/ejic.202100995] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Joshua J. Woods
- Cornell University Department of Chemistry and Chemical Biology 14853 Ithaca UNITED STATES
| | - Jesse A. Spivey
- Cornell University Department of Chemistry and Chemical Biology 14853 Ithaca UNITED STATES
| | - Justin J. Wilson
- Cornell University Department of Chemistry and Chemical Biology G50A Baker Laboratory 14853 Ithaca UNITED STATES
| |
Collapse
|
14
|
Sultana S, Noroozifar M, Kerman K. Ruthenium Red-functionalized sol-gel and multi-walled carbon nanotubes for electrochemical simultaneous detection of three dihydroxybenzene isomers. J Electroanal Chem (Lausanne) 2021. [DOI: 10.1016/j.jelechem.2021.115644] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Woods JJ, Rodriguez MX, Tsai CW, Tsai MF, Wilson JJ. Cobalt amine complexes and Ru265 interact with the DIME region of the mitochondrial calcium uniporter. Chem Commun (Camb) 2021; 57:6161-6164. [PMID: 34042919 DOI: 10.1039/d1cc01623g] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
We report our investigation into the MCU-inhibitory activity of Co3+ complexes in comparison to Ru265. These compounds reversibly inhibit the MCU with nanomolar potency. Mutagenesis studies and molecular docking simulations suggest that the complexes operate through interactions with the DIME motif of the MCU pore.
Collapse
Affiliation(s)
- Joshua J Woods
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA. and Robert F. Smith School for Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA
| | - Madison X Rodriguez
- Department of Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
| | - Chen-Wei Tsai
- Department of Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
| | - Ming-Feng Tsai
- Department of Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA.
| |
Collapse
|
16
|
De Mario A, Tosatto A, Hill JM, Kriston-Vizi J, Ketteler R, Vecellio Reane D, Cortopassi G, Szabadkai G, Rizzuto R, Mammucari C. Identification and functional validation of FDA-approved positive and negative modulators of the mitochondrial calcium uniporter. Cell Rep 2021; 35:109275. [PMID: 34161774 PMCID: PMC8242467 DOI: 10.1016/j.celrep.2021.109275] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 05/10/2021] [Accepted: 05/28/2021] [Indexed: 12/12/2022] Open
Abstract
The mitochondrial calcium uniporter (MCU), the highly selective channel responsible for mitochondrial Ca2+ entry, plays important roles in physiology and pathology. However, only few pharmacological compounds directly and selectively modulate its activity. Here, we perform high-throughput screening on a US Food and Drug Administration (FDA)-approved drug library comprising 1,600 compounds to identify molecules modulating mitochondrial Ca2+ uptake. We find amorolfine and benzethonium to be positive and negative MCU modulators, respectively. In agreement with the positive effect of MCU in muscle trophism, amorolfine increases muscle size, and MCU silencing is sufficient to blunt amorolfine-induced hypertrophy. Conversely, in the triple-negative breast cancer cell line MDA-MB-231, benzethonium delays cell growth and migration in an MCU-dependent manner and protects from ceramide-induced apoptosis, in line with the role of mitochondrial Ca2+ uptake in cancer progression. Overall, we identify amorolfine and benzethonium as effective MCU-targeting drugs applicable to a wide array of experimental and disease conditions. We screen an FDA-approved drug library for mitochondrial Ca2+ uptake modulators Amorolfine and benzethonium modulate MCU activity Amorolfine increases MCU-dependent mitochondrial metabolism and muscle size Benzethonium decreases MCU-dependent cancer cell growth and migration
Collapse
Affiliation(s)
- Agnese De Mario
- Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy
| | - Anna Tosatto
- Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy
| | - Julia Marie Hill
- Department of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London WC1E 6BT, UK
| | - Janos Kriston-Vizi
- Bioinformatics Image Core (BIONIC), MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK
| | - Robin Ketteler
- Cell Signalling and Autophagy Group, MRC Laboratory for Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, UK
| | | | - Gino Cortopassi
- Department of Molecular Bioscience, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA
| | - Gyorgy Szabadkai
- Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; Department of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London WC1E 6BT, UK; Francis Crick Institute, London WC1E 6BT, UK
| | - Rosario Rizzuto
- Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; Myology Center (CIR-Myo), University of Padua, 35131 Padua, Italy.
| | - Cristina Mammucari
- Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; Myology Center (CIR-Myo), University of Padua, 35131 Padua, Italy.
| |
Collapse
|
17
|
Novorolsky RJ, Nichols M, Kim JS, Pavlov EV, J Woods J, Wilson JJ, Robertson GS. The cell-permeable mitochondrial calcium uniporter inhibitor Ru265 preserves cortical neuron respiration after lethal oxygen glucose deprivation and reduces hypoxic/ischemic brain injury. J Cereb Blood Flow Metab 2020; 40:1172-1181. [PMID: 32126877 PMCID: PMC7238378 DOI: 10.1177/0271678x20908523] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/26/2019] [Revised: 12/18/2019] [Accepted: 01/31/2020] [Indexed: 01/20/2023]
Abstract
The mitochondrial calcium (Ca2+) uniporter (MCU) mediates high-capacity mitochondrial Ca2+ uptake implicated in ischemic/reperfusion cell death. We have recently shown that inducible MCU ablation in Thy1-expressing neurons renders mice resistant to sensorimotor deficits and forebrain neuron loss in a model of hypoxic/ischemic (HI) brain injury. These findings encouraged us to compare the neuroprotective effects of Ru360 and the recently identified cell permeable MCU inhibitor Ru265. Unlike Ru360, Ru265 (2-10 µM) reached intracellular concentrations in cultured cortical neurons that preserved cell viability, blocked the protease activity of Ca2+-dependent calpains and maintained mitochondrial respiration and glycolysis after a lethal period of oxygen-glucose deprivation (OGD). Intraperitoneal (i.p.) injection of adult male C57Bl/6 mice with Ru265 (3 mg/kg) also suppressed HI-induced sensorimotor deficits and brain injury. However, higher doses of Ru265 (10 and 30 mg/kg, i.p.) produced dose-dependent increases in the frequency and duration of seizure-like behaviours. Ru265 is proposed to promote convulsions by reducing Ca2+ buffering and energy production in highly energetic interneurons that suppress brain seizure activity. These findings support the therapeutic potential of MCU inhibition in the treatment of ischemic stroke but also indicate that such clinical translation will require drug delivery strategies which mitigate the pro-convulsant effects of Ru265.
Collapse
Affiliation(s)
- Robyn J Novorolsky
- Department of Pharmacology, Faculty of Medicine,
Dalhousie University, Life Sciences Research Institute, Halifax,
Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie
University, Life Sciences Research Institute, Halifax, Canada
| | - Matthew Nichols
- Department of Pharmacology, Faculty of Medicine,
Dalhousie University, Life Sciences Research Institute, Halifax,
Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie
University, Life Sciences Research Institute, Halifax, Canada
| | - Jong S Kim
- Department of Community Health and Epidemiology,
Faculty of Medicine, Centre for Clinical Research, Dalhousie
University, Halifax, Nova Scotia, Canada
- Department of Microbiology, Faculty of Medicine,
Centre for Clinical Research, Dalhousie University, Nova Scotia,
Canada
| | - Evgeny V Pavlov
- Department of Basic Sciences, College of Dentistry,
New York University, NY, USA
| | - Joshua J Woods
- Department of Chemistry and Chemical Biology, Cornell
University, Baker Laboratory, Ithaca, NY, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell
University, Baker Laboratory, Ithaca, NY, USA
| | - George S Robertson
- Department of Pharmacology, Faculty of Medicine,
Dalhousie University, Life Sciences Research Institute, Halifax,
Canada
- Brain Repair Centre, Faculty of Medicine, Dalhousie
University, Life Sciences Research Institute, Halifax, Canada
- Department of Psychiatry, Faculty of Medicine,
Dalhousie University, Life Sciences Research Institute, Halifax,
Canada
| |
Collapse
|
18
|
Woods JJ, Lovett J, Lai B, Harris HH, Wilson JJ. Redox Stability Controls the Cellular Uptake and Activity of Ruthenium‐Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU). Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202000247] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Joshua J. Woods
- Department of Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
- Robert F. Smith School for Chemical and Biomolecular Engineering Cornell University Ithaca NY 14853 USA
| | - James Lovett
- Department of Chemistry The University of Adelaide Adelaide SA 5005 Australia
| | - Barry Lai
- Advanced Photon Source X-ray Science Division Argonne National Laboratory Argonne IL 60439 USA
| | - Hugh H. Harris
- Department of Chemistry The University of Adelaide Adelaide SA 5005 Australia
| | - Justin J. Wilson
- Department of Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| |
Collapse
|
19
|
Lambert JP, Murray EK, Elrod JW. MCUB and mitochondrial calcium uptake - modeling, function, and therapeutic potential. Expert Opin Ther Targets 2020; 24:163-169. [PMID: 32093523 PMCID: PMC7078044 DOI: 10.1080/14728222.2020.1732926] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 02/18/2020] [Indexed: 01/06/2023]
Affiliation(s)
| | - Emma K Murray
- Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA, USA
| | - John W Elrod
- Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA, USA
| |
Collapse
|
20
|
Woods JJ, Lovett J, Lai B, Harris HH, Wilson JJ. Redox Stability Controls the Cellular Uptake and Activity of Ruthenium‐Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU). Angew Chem Int Ed Engl 2020; 59:6482-6491. [DOI: 10.1002/anie.202000247] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Indexed: 12/13/2022]
Affiliation(s)
- Joshua J. Woods
- Department of Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
- Robert F. Smith School for Chemical and Biomolecular Engineering Cornell University Ithaca NY 14853 USA
| | - James Lovett
- Department of Chemistry The University of Adelaide Adelaide SA 5005 Australia
| | - Barry Lai
- Advanced Photon Source X-ray Science Division Argonne National Laboratory Argonne IL 60439 USA
| | - Hugh H. Harris
- Department of Chemistry The University of Adelaide Adelaide SA 5005 Australia
| | - Justin J. Wilson
- Department of Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| |
Collapse
|
21
|
Misawa-Suzuki T, Watanabe T, Okamura M, Nanbu S, Nagao H. Framework Conversion of Oxido-Bridged Dinuclear Ruthenium Complexes. Inorg Chem 2019; 59:612-622. [DOI: 10.1021/acs.inorgchem.9b02850] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Tomoyo Misawa-Suzuki
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan
| | - Takashi Watanabe
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan
| | - Mariko Okamura
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan
| | - Shinkoh Nanbu
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan
| | - Hirotaka Nagao
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554, Japan
| |
Collapse
|
22
|
Woods JJ, Wilson JJ. Inhibitors of the mitochondrial calcium uniporter for the treatment of disease. Curr Opin Chem Biol 2019; 55:9-18. [PMID: 31869674 DOI: 10.1016/j.cbpa.2019.11.006] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Revised: 11/12/2019] [Accepted: 11/15/2019] [Indexed: 01/04/2023]
Abstract
The mitochondrial calcium uniporter (MCU) is a protein located in the inner mitochondrial membrane that is responsible for mitochondrial Ca2+ uptake. Under certain pathological conditions, dysregulation of Ca2+ uptake through the MCU results in cellular dysfunction and apoptotic cell death. Given the role of the MCU in human disease, researchers have developed compounds capable of inhibiting mitochondrial calcium uptake as tools for understanding the role of this protein in cell death. In this article, we describe recent findings on the role of the MCU in mediating pathological conditions and the search for small-molecule inhibitors of this protein for potential therapeutic applications.
Collapse
Affiliation(s)
- Joshua J Woods
- Robert F. Smith School for Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14583, USA
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14583, USA.
| |
Collapse
|
23
|
Woods J, Nemani N, Shanmughapriya S, Kumar A, Zhang M, Nathan SR, Thomas M, Carvalho E, Ramachandran K, Srikantan S, Stathopulos PB, Wilson JJ, Madesh M. A Selective and Cell-Permeable Mitochondrial Calcium Uniporter (MCU) Inhibitor Preserves Mitochondrial Bioenergetics after Hypoxia/Reoxygenation Injury. ACS CENTRAL SCIENCE 2019; 5:153-166. [PMID: 30693334 PMCID: PMC6346394 DOI: 10.1021/acscentsci.8b00773] [Citation(s) in RCA: 99] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Indexed: 05/10/2023]
Abstract
Mitochondrial Ca2+ (mCa2+) uptake mediated by the mitochondrial calcium uniporter (MCU) plays a critical role in signal transduction, bioenergetics, and cell death, and its dysregulation is linked to several human diseases. In this study, we report a new ruthenium complex Ru265 that is cell-permeable, minimally toxic, and highly potent with respect to MCU inhibition. Cells treated with Ru265 show inhibited MCU activity without any effect on cytosolic Ca2+ dynamics and mitochondrial membrane potential (ΔΨm). Dose-dependent studies reveal that Ru265 is more potent than the currently employed MCU inhibitor Ru360. Site-directed mutagenesis of Cys97 in the N-terminal domain of human MCU ablates the inhibitory activity of Ru265, suggesting that this matrix-residing domain is its target site. Additionally, Ru265 prevented hypoxia/reoxygenation injury and subsequent mitochondrial dysfunction, demonstrating that this new inhibitor is a valuable tool for studying the functional role of the MCU in intact biological models.
Collapse
Affiliation(s)
- Joshua
J. Woods
- Robert
F. Smith School for Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, United States
- Department
of Chemistry and Chemical Biology, Cornell
University, Ithaca, New York 14853, United
States
| | - Neeharika Nemani
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
| | - Santhanam Shanmughapriya
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
| | - Akshay Kumar
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
| | - MengQi Zhang
- Department
of Physiology and Pharmacology, Western
University, London, Ontario N6A 5C1, Canada
| | - Sarah R. Nathan
- Department
of Chemistry and Chemical Biology, Cornell
University, Ithaca, New York 14853, United
States
| | - Manfred Thomas
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
| | - Edmund Carvalho
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
| | - Karthik Ramachandran
- Department
of Medicine/Nephrology, Institute for Precision Medicine and Health, University of Texas Health San Antonio, San Antonio, Texas 78229, United States
| | - Subramanya Srikantan
- Department
of Medicine/Nephrology, Institute for Precision Medicine and Health, University of Texas Health San Antonio, San Antonio, Texas 78229, United States
| | - Peter B. Stathopulos
- Department
of Physiology and Pharmacology, Western
University, London, Ontario N6A 5C1, Canada
| | - Justin J. Wilson
- Department
of Chemistry and Chemical Biology, Cornell
University, Ithaca, New York 14853, United
States
| | - Muniswamy Madesh
- Department
of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Center
for Translational Medicine, Lewis Katz School
of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
- Department
of Medicine/Nephrology, Institute for Precision Medicine and Health, University of Texas Health San Antonio, San Antonio, Texas 78229, United States
| |
Collapse
|
24
|
Drumm BT, Sung TS, Zheng H, Baker SA, Koh SD, Sanders KM. The effects of mitochondrial inhibitors on Ca 2+ signalling and electrical conductances required for pacemaking in interstitial cells of Cajal in the mouse small intestine. Cell Calcium 2018; 72:1-17. [PMID: 29748128 DOI: 10.1016/j.ceca.2018.01.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Revised: 01/26/2018] [Accepted: 01/27/2018] [Indexed: 01/16/2023]
Abstract
Interstitial cells of Cajal (ICC-MY) are pacemakers that generate and propagate electrical slow waves in gastrointestinal (GI) muscles. Slow waves appear to be generated by the release of Ca2+ from intracellular stores and activation of Ca2+-activated Cl- channels (Ano1). Conduction of slow waves to smooth muscle cells coordinates rhythmic contractions. Mitochondrial Ca2+ handling is currently thought to be critical for ICC pacemaking. Protonophores, inhibitors of the electron transport chain (FCCP, CCCP or antimycin) or mitochondrial Na+/Ca2+ exchange blockers inhibited slow waves in several GI muscles. Here we utilized Ca2+ imaging of ICC in small intestinal muscles in situ to determine the effects of mitochondrial drugs on Ca2+ transients in ICC. Muscles were obtained from mice expressing a genetically encoded Ca2+ indicator (GCaMP3) in ICC. FCCP, CCCP, antimycin, a uniporter blocker, Ru360, and a mitochondrial Na+/Ca2+ exchange inhibitor, CGP-37157 inhibited Ca2+ transients in ICC-MY. Effects were not due to depletion of ATP, as oligomycin did not affect Ca2+ transients. Patch-clamp experiments were performed to test the effects of the mitochondrial drugs on key pacemaker conductances, Ano1 and T-type Ca2+ (CaV3.2), in HEK293 cells. Antimycin blocked Ano1 and reduced CaV3.2 currents. CCCP blocked CaV3.2 current but did not affect Ano1 current. Ano1 and Cav3.2 currents were inhibited by CGP-37157. Inhibitory effects of mitochondrial drugs on slow waves and Ca2+ signalling in ICC can be explained by direct antagonism of key pacemaker conductances in ICC that generate and propagate slow waves. A direct obligatory role for mitochondria in pacemaker activity is therefore questionable.
Collapse
Affiliation(s)
- Bernard T Drumm
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA
| | - Tae S Sung
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA
| | - Haifeng Zheng
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA
| | - Salah A Baker
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA
| | - Sang D Koh
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA
| | - Kenton M Sanders
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA.
| |
Collapse
|
25
|
Nathan SR, Pino NW, Arduino DM, Perocchi F, MacMillan SN, Wilson JJ. Synthetic Methods for the Preparation of a Functional Analogue of Ru360, a Potent Inhibitor of Mitochondrial Calcium Uptake. Inorg Chem 2017; 56:3123-3126. [DOI: 10.1021/acs.inorgchem.6b03108] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Sarah R. Nathan
- Department of Chemistry
and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Nicholas W. Pino
- Department of Chemistry
and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Daniela M. Arduino
- Gene Center, Department of Biochemistry, Ludwig-Maximilans Universität München, Munich, Germany
- Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany
| | - Fabiana Perocchi
- Gene Center, Department of Biochemistry, Ludwig-Maximilans Universität München, Munich, Germany
- Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany
| | - Samantha N. MacMillan
- Department of Chemistry
and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Justin J. Wilson
- Department of Chemistry
and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| |
Collapse
|
26
|
Abstract
Ruthenium is seldom mentioned in microbiology texts, due to the fact that this metal has no known, essential roles in biological systems, nor is it generally considered toxic. Since the fortuitous discovery of cisplatin, first as an antimicrobial agent and then later employed widely as an anticancer agent, complexes of other platinum group metals, such as ruthenium, have attracted interest for their medicinal properties. Here, we review at length how ruthenium complexes have been investigated as potential antimicrobial, antiparasitic and chemotherapeutic agents, in addition to their long and well-established roles as biological stains and inhibitors of calcium channels. Ruthenium complexes are also employed in a surprising number of biotechnological roles. It is in the employment of ruthenium complexes as antimicrobial agents and alternatives or adjuvants to more traditional antibiotics, that we expect to see the most striking developments in the future. Such novel contributions from organometallic chemistry are undoubtedly sorely needed to address the antimicrobial resistance crisis and the slow appearance on the market of new antibiotics.
Collapse
|
27
|
Urgiles J, Nathan SR, MacMillan SN, Wilson JJ. Dinuclear nitrido-bridged ruthenium complexes bearing diimine ligands. Dalton Trans 2017; 46:14256-14263. [DOI: 10.1039/c7dt03085a] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Nitrido-bridged ruthenium complexes are synthesized via ligand substitution reactions and evaluated for mitochondrial calcium uptake inhibition.
Collapse
Affiliation(s)
- Julie Urgiles
- Department of Chemistry and Chemical Biology
- Cornell University
- Ithaca
- USA
| | - Sarah R. Nathan
- Department of Chemistry and Chemical Biology
- Cornell University
- Ithaca
- USA
| | | | - Justin J. Wilson
- Department of Chemistry and Chemical Biology
- Cornell University
- Ithaca
- USA
| |
Collapse
|
28
|
Sánchez-Segura L, Téllez-Medina D, Evangelista-Lozano S, García-Armenta E, Alamilla-Beltrán L, Hernández-Sánchez H, Jiménez-Aparicio A, Gutiérrez-López G. Morpho-structural description of epidermal tissues related to pungency of Capsicum species. J FOOD ENG 2015. [DOI: 10.1016/j.jfoodeng.2014.11.022] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
29
|
Suzuki T, Matsuya K, Kawamoto T, Nagao H. Synthesis and Structures of Mixed-Valence Oxido-Bridged Diruthenium Complexes Bearing Ethylbis(2-pyridylmethyl)amine. Eur J Inorg Chem 2013. [DOI: 10.1002/ejic.201301070] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
30
|
Jurss JW, Concepcion JJ, Butler JM, Omberg KM, Baraldo LM, Thompson DG, Lebeau EL, Hornstein B, Schoonover JR, Jude H, Thompson JD, Dattelbaum DM, Rocha RC, Templeton JL, Meyer TJ. Electronic Structure of the Water Oxidation Catalyst cis,cis-[(bpy)2(H2O)RuIIIORuIII(OH2)(bpy)2]4+, The Blue Dimer. Inorg Chem 2012; 51:1345-58. [DOI: 10.1021/ic201521w] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Jonah W. Jurss
- Department of Chemistry, University of North Carolina, Chapel
Hill, North Carolina 27599-3290, United States
| | - Javier J. Concepcion
- Department of Chemistry, University of North Carolina, Chapel
Hill, North Carolina 27599-3290, United States
| | | | | | | | | | | | | | | | | | | | | | | | - Joseph L. Templeton
- Department of Chemistry, University of North Carolina, Chapel
Hill, North Carolina 27599-3290, United States
| | - Thomas J. Meyer
- Department of Chemistry, University of North Carolina, Chapel
Hill, North Carolina 27599-3290, United States
| |
Collapse
|
31
|
Romańczyk PP, Noga K, Włodarczyk AJ, Nitek W, Broclawik E. Torsionally Controlled Electronic Coupling in Mixed-Valence Oxodimolybdenum Nitrosyl Scorpionates - a DFT Study. Inorg Chem 2010; 49:7676-84. [DOI: 10.1021/ic100024h] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Piotr P. Romańczyk
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, 31-155 Kraków, Poland
| | - Klemens Noga
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland
| | - Andrzej J. Włodarczyk
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, 31-155 Kraków, Poland
| | - Wojciech Nitek
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland
| | - Ewa Broclawik
- Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, ul. Niezapominajek 8, 30-239 Kraków, Poland
| |
Collapse
|
32
|
Lopes LMF, Garcia AR, Brogueira P, Ilharco LM. Interactions between DNA Purines and Ruthenium Ammine Complexes within Nanostructured Sol−Gel Silica Matrixes. J Phys Chem B 2010; 114:3987-98. [DOI: 10.1021/jp9080542] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Luís M. F. Lopes
- CQFM - Centro de Química-Física Molecular and IN - Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal, Departamento de Química e Farmácia, FCT, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal, and Departamento de Física and ICEMS, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
| | - Ana R. Garcia
- CQFM - Centro de Química-Física Molecular and IN - Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal, Departamento de Química e Farmácia, FCT, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal, and Departamento de Física and ICEMS, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
| | - Pedro Brogueira
- CQFM - Centro de Química-Física Molecular and IN - Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal, Departamento de Química e Farmácia, FCT, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal, and Departamento de Física and ICEMS, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
| | - Laura M. Ilharco
- CQFM - Centro de Química-Física Molecular and IN - Institute of Nanoscience and Nanotechnology, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal, Departamento de Química e Farmácia, FCT, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal, and Departamento de Física and ICEMS, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal
| |
Collapse
|
33
|
Murali M, Mayilmurugan R, Palaniandavar M. Synthesis, Structure and Spectral, and Electrochemical Properties of New Mononuclear Ruthenium(III) Complexes of Tris[(benzimidazol-2-yl)methyl]amine: Role of Steric Hindrance in Tuning the Catalytic Oxidation Activity. Eur J Inorg Chem 2009. [DOI: 10.1002/ejic.200900119] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
34
|
|
35
|
Appendino G, Szallasi A. 4 Clinically Useful Vanilloid Receptor TRPV1 Antagonists: Just around the Corner (or too Early to Tell)? PROGRESS IN MEDICINAL CHEMISTRY 2006; 44:145-80. [PMID: 16697897 DOI: 10.1016/s0079-6468(05)44404-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Giovanni Appendino
- Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, Università del Piemonte Orientale, Novara, Italy
| | | |
Collapse
|
36
|
|
37
|
Abdur-Rashid K, Clapham SE, Hadzovic A, Harvey JN, Lough AJ, Morris RH. Mechanism of the hydrogenation of ketones catalyzed by trans-dihydrido(diamine)ruthenium II complexes. J Am Chem Soc 2002; 124:15104-18. [PMID: 12475357 DOI: 10.1021/ja016817p] [Citation(s) in RCA: 435] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The complexes trans-RuH(Cl)(tmen)(R-binap) (1) and (OC-6-43)-RuH(Cl)(tmen)(PPh(3))(2) (2) are prepared by the reaction of the diamine NH(2)CMe(2)CMe(2)NH(2) (tmen) with RuH(Cl)(PPh(3))(R-binap) and RuH(Cl)(PPh(3))(3), respectively. Reaction of KHB(sec)Bu(3) with 1 yields trans-Ru(H)(2)(R-binap)(tmen) (5) while reaction of KHB(sec)Bu(3) or KO(t)Bu with 2 under Ar yields the new hydridoamido complex RuH(PPh(3))(2)(NH(2)CMe(2)CMe(2)NH) (4). Complex 4 has a distorted trigonal bipyramidal geometry with the amido nitrogen in the equatorial plane. Loss of H(2) from 5 results in the related complex RuH(R-binap)(NH(2)CMe(2)CMe(2)NH) (3). Reaction of H(2) with 4 yields the trans-dihydride (OC-6-22)-Ru(H)(2)(PPh(3))(2)(tmen)(6). Calculations support the assignment of the structures. The hydrogenation of acetophenone is catalyzed by 5 or 4 in benzene or 2-propanol without the need for added base. For 5 in benzene at 293 K over the ranges of concentrations [5] = 10(-)(4) to 10(-)(3) M, [ketone] = 0.1 to 0.5 M, and of pressures of H(2) = 8 to 23 atm, the rate law is rate = k[5][H(2)] with k = 3.3 M(-1) s(1), DeltaH++ = 8.5 +/- 0.5 kcal mol(-1), DeltaS++ = -28 +/- 2 cal mol(-1) K(-1). For 4 in benzene at 293 K over the ranges of concentrations [4] = 10(-4) to 10(-3) M, [ketone] 0.1 to 0.7 M, and of pressures of H(2) = 1 to 6 atm, the preliminary rate law is rate = k[4][H(2)] with k = 1.1 x 10(2) M(-1) s(-1), DeltaH++ = 7.6 +/- 0.3 kcal mol(-1), DeltaS++ = -23 +/- 1 cal mol(-1) K(-1). Both theory and experiment suggest that the intramolecular heterolytic splitting of dihydrogen across the polar Ru=N bond of the amido complexes 3 and 4 is the turn-over limiting step. A transition state structure and reaction energy profile is calculated. The transfer of H(delta+)/H(delta-) to the ketone from the RuH and NH groups of 5 in a Noyori metal-ligand bifunctional mechanism is a fast process and it sets the chirality as (R)-1-phenylethanol (62-68% ee) in the hydrogenation of acetophenone. The rate of hydrogenation of acetophenone catalyzed by 5 is slower and the ee of the product is low (14% S) when 2-propanol is used as the solvent, but both the rate and ee (up to 55% R) increase when excess KO(t)Bu is added. The formation of ruthenium alkoxide complexes in 2-propanol might explain these observations. Alkoxide complexes [RuP(2)]H(OR)(tmen), [RuP(2)] = Ru(R-binap) or Ru(PPh(3))(2), R= (i) Pr, CHPhMe, (t)Bu, are observed by reacting the alcohols (i)PrOH, phenylethanol, and (t)BuOH with the dihydrides 5 and 6, respectively, under Ar. In the absence of H(2), the amido complexes 3 and 4 react with acetophenone to give the ketone adducts [RuP(2)]H(O=CPhMe)(NH(2)CMe(2)CMe(2)NH) in equilibrium with the enolate complexes trans- [RuP(2)](H)(OCPh=CH(2))(tmen) and eventually the decomposition products [RuP(2)]H(eta(5)-CH(2)CPhCHCPhO), with the binap complex characterized crystallographically. In general, proton transfer from the weakly acidic molecules dihydrogen, alcohol, or acetophenone to the amido nitrogen of complexes 3 and 4 is favored in two ways when the molecule coordinates to ruthenium: (1) an increase in acidity of the molecule by the Lewis acidic metal and (2) an increase in the basicity of the amido nitrogen caused by its pyramidalization. The formato complexes trans-[RuP(2)]H(OCHO)(tmen) were prepared by reacting the respective complex 4 or 5 with formic acid. The crystal structure of RuH(OCHO)(PPh(3))(2)(tmen) displays similar features to the calculated transition state for H(delta+)/H(delta-) transfer to the ketone in the catalytic cycle.
Collapse
Affiliation(s)
- Kamaluddin Abdur-Rashid
- Department of Chemistry, Davenport Laboratories, University of Toronto, 80 St George Street, Toronto, Ontario M5S 3H6, Canada
| | | | | | | | | | | |
Collapse
|
38
|
|
39
|
Abe T, Goto T, Ohzeki K, Kaneko M. Electrocatalysis for proton reduction by a coated Nafion® membrane dispersing ruthenium moieties. Electrochim Acta 2000. [DOI: 10.1016/s0013-4686(00)00486-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Clarke MJ, Zhu F, Frasca DR. Non-platinum chemotherapeutic metallopharmaceuticals. Chem Rev 1999; 99:2511-34. [PMID: 11749489 DOI: 10.1021/cr9804238] [Citation(s) in RCA: 739] [Impact Index Per Article: 29.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- M J Clarke
- Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467
| | | | | |
Collapse
|
41
|
Kojima T, Amano T, Ishii Y, Ohba M, Okaue Y, Matsuda Y. Synthesis and Characterization of Mononuclear and Dinuclear Ruthenium Complexes with Tris(2-pyridylmethyl)amine and Tris(5-methyl-2-pyridylmethyl)amine. Inorg Chem 1998; 37:4076-4085. [PMID: 11670527 DOI: 10.1021/ic971049h] [Citation(s) in RCA: 89] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Novel Ru(II) and Ru(III) complexes having TPA (tris(2-pyridylmethyl)amine, L1) and 5-Me(3)-TPA (tris(5-methyl-2-pyridylmethyl)amine, L2) were prepared to establish their synthetic routes and to elucidate coordination geometry and interactions between tightly bound tripodal tetradentate ligands and Ru(II)/Ru(III) centers. They include mononuclear Ru(II) complexes [RuCl(DMSO)(L)]ClO(4) (1 (L1), 2 (L2)), dinuclear bis-&mgr;-chloro Ru(II) complexes [RuCl(L)](2)(ClO(4))(2) (3 (L1), 4 (L2)), and mononuclear Ru(III) complexes [RuCl(2)(L)]ClO(4) (5 (L1), 6 (L2)). They were characterized by X-ray crystallography (for 2, 3, and 5), (1)H NMR spectroscopy, and cyclic voltammetry. For compound 2, the crystal structure was determined to possess S-bound DMSO ligand which was trans to pyridine and Cl(-) trans to the tertiary amino group of L2, and this isomer was obtained exclusively. Complex 1 was also isolated as a single isomer. Complex 3 was revealed to be a dinuclear bis-&mgr;-chloro Ru(II) species with the center of symmetry midway between two Cl(-). (1)H NMR spectra of Ru(II) complexes 1-4, the molecular structure of 2, and comparison of the molecular structure of 3 with 5 suggest that the interaction between the Ru(II) center, pyridyl moieties, and the DMSO ligand is strengthened by pi-back-bonding from the Ru(II) center to the ligands in addition to sigma-bonding of the tertiary amino group. Electrochemical measurements on 1-6 in CH(3)CN revealed that the methyl groups on pyridyl rings exert electron-donating effects onto the Ru centers to lower each redox process and such effect strengthens the Ru-S bonding in 2 compared with that in 1, accommodating pi-back-bonding from Ru(II) center to other pi-acceptors such as DMSO in 2 enough to prevent isomerization of DMSO binding mode. The dinuclear complexes 3 and 4 showed relatively large comproportionation constants, which suggest mixed-valent Ru(II)Ru(III) states would be stabilized.
Collapse
Affiliation(s)
- Takahiko Kojima
- Department of Chemistry, Faculty of Science, Kyushu University, Hakozaki, Higashi-Ku, Fukuoka 812-81, Japan, and Department of Chemistry and Biotechnology, The Graduate School of Engineering, The University of Tokyo, Hongo, Bunkyo-Ku, Tokyo 113, Japan
| | | | | | | | | | | |
Collapse
|
42
|
Matlib MA, Zhou Z, Knight S, Ahmed S, Choi KM, Krause-Bauer J, Phillips R, Altschuld R, Katsube Y, Sperelakis N, Bers DM. Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem 1998; 273:10223-31. [PMID: 9553073 DOI: 10.1074/jbc.273.17.10223] [Citation(s) in RCA: 253] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J., Ying, W-L., and Sanadi, D. R. (1993) J. Am. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+-stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (Kd = 0.34 nM, Bmax = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 microM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L-type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent biphasic manner. Ru360 (10 microM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.
Collapse
Affiliation(s)
- M A Matlib
- Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio 45267-0575, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Koshi C, Umakoshi K, Sasaki Y. Oxo-single-bridged and Oxo-carboxylato-double-bridged Diruthenium(III) Complexes of Tris(2-pyridylmethyl)amine. CHEM LETT 1997. [DOI: 10.1246/cl.1997.1155] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
44
|
|
45
|
|
46
|
Takahira T, Umakoshi K, Sasaki Y. Dinuclear Rhenium(III) Complexes with a Single Oxide Bridge, [Re2(μ-O)Cl2(L)2]2+(L = 2,2′-Bipyridine or 1,10-Phenanthroline). CHEM LETT 1994. [DOI: 10.1246/cl.1994.2315] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
47
|
Broekemeier KM, Krebsbach RJ, Pfeiffer DR. Inhibition of the mitochondrial Ca2+ uniporter by pure and impure ruthenium red. Mol Cell Biochem 1994; 139:33-40. [PMID: 7531818 DOI: 10.1007/bf00944201] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Commercial ruthenium red is often purified by a single recrystallization as described by Luft, J.H. (1971) Anat Rec 171, 347-368, which yields small amounts of material having an apparent molar extinction coefficient of approximately 67,400 at 533 nm. A simple modification to the procedure dramatically improves the yield, allowing crystallization to be repeated. Three times recrystallized ruthenium red has an apparent extinction coefficient of approximately 85,900, the highest value reported to date. Both crude and highly purified ruthenium red can be shown to inhibit reverse activity of the mitochondrial Ca2+ uniporter (uncoupled mitochondria), provided that care is taken to minimize and account for Ca2+ release through the permeability transition pore. Crude ruthenium red is 7-10 fold more potent than the highly purified material in this regard, on an actual ruthenium red concentration basis. The same relative potency is seen against forward uniport (coupled mitochondria), however, the I50 values are 10 fold lower for both the crude and purified preparations. These data demonstrate unambiguously that the energy state of mitochondria affects the sensitivity of the Ca2+ uniporter to ruthenium red preparations, and that both the forward and reverse reactions are subject to complete inhibition. The data suggest, however, that the active inhibitor may not be ruthenium red per se, but one or more of the other ruthenium complexes which are present in ruthenium red preparations.
Collapse
Affiliation(s)
- K M Broekemeier
- Ohio State University, Department of Medical Biochemistry, Columbus 43210-1218
| | | | | |
Collapse
|